Text Size

Are we Loading Our Patients With Sodium During Hemodialysis Treatments?

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Renal Research Institute
ClinicalTrials.gov Identifier:
NCT01454193
First received: October 13, 2011
Last updated: October 18, 2011
Last verified: October 2011
History of Changes
  Purpose

The objectives of the data search is to find out if there is correlation between pre, post serum sodium concentration, dialysate sodium concentration, interdialytic weight gain and associated changes in pre and post systolic and diastolic blood pressure, mean arterial pressure, number of blood pressure medications and adherence to 3 times per week dialysis, mortality.


Condition
Renal Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Resource links provided by NLM:

MedlinePlus related topics: Dialysis
U.S. FDA Resources

Further study details as provided by Renal Research Institute:

Enrollment: 10000
Study Start Date: January 2001
Study Completion Date: October 2011
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 88 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Hemodialysis patients at Renal Research Institute and Fresenius clinics

Criteria

Inclusion Criteria:

  • Hemodialysis patient
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01454193

Locations
United States, New York
Renal Research Institute
New York, New York, United States, 10128
Sponsors and Collaborators
Renal Research Institute
Investigators
Principal Investigator: Peter Kotanko, MD Renal Research Institute
  More Information

No publications provided

Responsible Party: Renal Research Institute
ClinicalTrials.gov Identifier: NCT01454193     History of Changes
Other Study ID Numbers: 078-08
Study First Received: October 13, 2011
Last Updated: October 18, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on May 23, 2013